Amarantus Bioscience Holdings Inc (AMBS)

[sante1]

Uplisting without a R/S? In one of his older reviews Gerald has stated this as we all know. Is this possible I asked myself?

What is the minimal requirement? $2.00 and AMBS has to hold that level for some time before it actually can be traded at the Nasdaq.

Can the good news show which we may expect according to Gerald bring AMBS to that level?

Personally I don't think so it will happen in the short term. If so it would be short lifted.

I and lots among myself, I believe ,are already happy if it will be trading in the one dollar range. at that time.

Perhaps if the Market shows lots of interests for the LYMPRO test and if AMBS finds a partner with great interest who is willing to invest a great amount of money in this company.

For one thing I'm sure if Gerald's outcome is true It's the last time we'll see the low $0.20.

Your opinion please.